Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7050 and Lenvatinib in Advanced Solid Tumors, Glioblastoma, and Melanoma
NCT01433991Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Golvatinib in solid tumor (advanced stage), glioblastoma (GBM), melanoma, sponsored by Eisai Co., Ltd.. Started Oct 2011; status: terminated.
02
Drugs
Golvatinib
03
Conditions
solid tumor (advanced stage)glioblastoma (GBM)melanoma
Beyond the preview
Go deeper on NCT01433991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433991.